On December 11, AALS presented a live demo and tutorial of the Neuromine Data Portal. This webinar showed researchers, clinicians, and data scientists how to harness ALS’s most comprehensive open-access data resource (over 150+ TB of multiomics and clinical data from more than 2,500 patients). Supported and maintained by the Answer ALS Foundation, Neuromine brings…
All data from 1,100+ Answer ALS participants, including ALS TDI’s ARC study data, are now harmonized and accessible via the Neuromine Data Portal, forming the world’s largest open ALS research resource to accelerate discoveries. NEW ORLEANS, November 03, 2025 — Answer ALS today announced the full release of its comprehensive ALS clinical and multi-omics dataset,…
NEW ORLEANS, La. [February 2025]: Answer ALS co-hosted the Game Changer Gala with Team Gleason during Super Bowl LIX week, bringing together leaders from sports, technology, research, philanthropy, and the arts to raise support for ALS research and patient empowerment. The Gala took place at the Mardi Gras World Float Den Annex and celebrated the…
WASHINGTON, D.C. [May 30, 2024]: Answer ALS hosted the inaugural IgNight ALS, a program that convened leaders from science, technology, policy, and culture to honor Steve Gleason and to highlight the spark that occurs when these disciplines work together on ALS. Gleason signed copies of his new book, A Life Impossible: Living with ALS: Finding…
Data & TechnologyHarnessing Big Data with Advanced Analytics Neuromine is one of the world’s most robust and comprehensive ALS data resources, integrating multi-omics, clinical, and cellular datasets, while also linking to coordinating iPSC lines, biosamples, and other large-scale data platforms with analytic tools to maximize discovery and collaboration.
Multi-Omnics AnalysisComprehensive Biological Data Integration Making a comprehensive multi-omics datasets available that integrates genomics, transcriptomics, proteomics, epigenomics, and iPSC-derived motor neuron data that is freely accessible for analysis.
IPS Cells & Motor NeuronsGenerated 1,000 Participant-Derived Cell Lines Learn More about how to access 1,000 iPSC lines through our partners at the Cedars-Sinai Biomanufacturing Center
Clinic & enrollmentLeading Clinics Engaged to Complete Enrollment Enrollment in the Answer ALS program is complete, but you can Learn More about connected programs like Champion Insights, ALS Therapy Development’s ARC Program
